1-3 of 3
Sheila Phang
Close
Sort by
Journal Articles

Utility Of An Algorithm For Use Of Plerixafor In Filgrastim-based Hematopoietic Progenitor Cell Mobilization In Patients With Plasma Cell Myeloma Treated With Carfilzomib-Lenalidomide-Dexamethasone.

Susan F. Leitman, MD, Nishant Tageja, MD, Neha Korde, MD, Yu Ying Yau, RN, Sheila Phang, RN, Jennifer Hsu, RN, Kristin Cole, RN, Hanh Khuu, MD, Ola Landgren, MD, PhD, Claude Sportes, MD
Journal: Blood
Blood (2013) 122 (21): 906.
https://doi.org/10.1182/blood.V122.21.906.906
Published: 2013
Journal Articles

Carfilzomib and Bortezomib Containing Regimens Yield High Rates Of MRD Negative Autologous Hematopoietic Progenitor Cell (HPC) Grafts In Multiple Myeloma (MM) and High Risk Smoldering Myeloma (SMM)

Nishant Tageja, MD, Neha Korde, MD, Constance Yuan, MD, PhD, Kristen Cole, RN, Jennifer Hsu, RN, Sheila Phang, RN, Daniele N. Avila, CRNP, Tiffany Taylor, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Hanh Khuu, MD, Maryalice Stetler-Stevenson, MD, PhD, Susan F. Leitman, MD, Ola Landgren, MD, PhD, Claude Sportes, MD
Journal: Blood
Blood (2013) 122 (21): 2030.
https://doi.org/10.1182/blood.V122.21.2030.2030
Published: 2013
Journal Articles

Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome

Clinical Trials & Observations Brief Report
Elizabeth M. Kang, Moniek de Witte, Harry Malech, Richard A. Morgan, Sheila Phang, Charles Carter, Susan F. Leitman, Richard Childs, A. John Barrett, Richard Little, John F. Tisdale
Journal: Blood
Blood (2002) 99 (2): 698–701.
https://doi.org/10.1182/blood.V99.2.698
Published: 2002